Newsletters


Medicines Optimisation teams produce monthly newsletters for prescribers.

Wilts CCG Newsletters are available through an NHS N3 connection at https://prescribing.wiltshireccg.nhs.uk/ or by contacting prescribingwiltshire@nhs.net

 

BaNES CCG Newsletters can be found listed below

Date           

Includes

 Apr/May 2018

 Feb/Mar 2018

 Jan 2018

Dec 2017

 Nov 2017  Recombinant human erythropoietins - risk of severe cutaneous adverse reactiions, Clozapine - reminder of potentially fatal risk of intestinal obstruction, faecal impaction and paralytic ileus, Osteosporosis; assessing the risk of fragility structure, BCAP onto TPP viability survey, Proposal to make pregabalin and gabapentin controoled drugs, How to document red drugs on TPP and EMIS, Diabetes updates - Freestyle Libre, caution in prescribing high strength insulins and Six Steps Insulin Safety course.
 Oct 2017 Gabapentin; risk of severe respiratory disease, New in BNF and BNFC has enhanced interactions included, Trifluoperazine - supply issues, Miconazole OTC oral gel contraindicated in patients taking warfarin, Loperamide reports of serious cardiac adverse reactions with high doses associated with abuse or misuse, Management of infection guidance.
 Sept 2017 Adrenaline auto-injector advice for patients - need to carry 2 pens at all times, Cortocosteroids - rare risk of central serous chorioretinopathy with local as well as systemic admisnistration, Safety concerns with mefenamic acid 500mg tablets, Warning re issued about sodium valproate prescribing in women of child bearing age, Global shortage of hepatitis b vaccine, NICE Bites - Parkinson's disease in adults, Braltus Zonda preferred tiotropium brand, Dovonex 50microgram/g ointment soon to be available OTC for psoriasis, Quetiapine XL and Rivastigmine patches to be prescribed as branded Zaluron and Alest respectively.
 July 2017 Documentation of red drugs on clinical systems, CD prescribing and what can go wrong, E-cigarettes and the Yellow Card reporting scheme, Daclizumab and risk of severe liver disease, PresQIPP deprescribing resources, New BNF and BNFC app launched, Update on Dressings Project and Optimise Rx.
June 2017 Quinine not to be used routinely for leg cramps, Denosumab reports of osteonecrosis of the external auditory canal, aspirin and PPIs, Brimimonidine gel (Mirvaso) risk of systemic cardiovascular effect plus non formulary, quick reference guide to emollient cost effective prescribing, Lyrica will switch back to pregabalin wef from 17.07.2017, use of rivaroxaban for suspected DVT pre diagnosis, Stontium Ranelate discontinued, Ulipristol updates. 
 May 2017 MHRA Safety Alert - Valproate and the risks to unborn babies, Asthma patients who are using a high quantity of SABAs, Community pharmacy and the issuing of Levonorgestral for emergency hormonal contraception and Azithromycin for chlamydia, Advice on Lyme disease management, Relocation of sexula health clinic.
Apr 2017 Canagliflozin MHRA update, fire risks and parafin based products, cardiac warning for anticholinergic injection, Pradaxa capsules colour change, ISMN MR 60mg - halving tablets, Optimise Rx brief introduction, prescribing medications fro patients leaving the country for longer than 3 months.
Feb/Mar 2017 Guidance on blood glocose monitoring, UKIG standards for reviewing inhaler technique, macrolides and other enzyme inhibitors with tacrolimus and ciclosporin, risk of hospital admissions for heart failure with nsaids, gluten free prescribing and OTC medications for short term ailments, buprenorphine to Butec switch, patients intolerant of statins - are fibrates still an option?, BaNES Public Health audit on communtity pharmacy skills.
Jan 2017  Risk of severe harm or death due to withdrawing insulin from pen devices, AWP sodium valproate guidance, Dressings optimisation project, Aveeno no longer on the formulary, use aspirin ec to reduce gastointestinal side effects in cardiovascular patients - is this supported by evidence?
Dec 2016 EMA extends use of metformin to patients with moderately reduced kidney function, incident with Sacubitril/Valsartan(Entresto), e gigarettes guidance, Sharps bins now available on FP10 in several sizes.
Oct 2016 Methotrexate 10mg - high risk of serious errors, revised dose of Etoricoxib recommended for Ra and AS, high strength insulins not to be prescribed in primary care, BTS/SIGN updated asthma guidance,Eppinix XL name change to Ipinnia XL, changes to Home Oxygen provision. 
 Sept 2016 Morphine sulphate 10mg/5ml oral solution, risk of extracting insulin from pen devices, errors in BNF app on some apple devices, Levonorgestrel double dose in women taking enzyme inducing medications, GnRH analogues, AKI patient safety alert, Sepis - NICE Bites, generic to branded switch recommendations.
 July 2016  Fentanyl patches, Tamoxifen and antidepressants, CD guidelines, Paraffin based emollients, Warfarin, Citalopram, Nystatin oral suspension, Sevelamer Carbonate
 June 2016  Canagliflozin, Dapagliflozin, topical Miconazole, Haloperidol, Evolocumab, Alirocumab,
 May 2016 Fluoroquinolones, NSAIDS in children with chickenpox, Sacubitril valsartan (Entresto®), Lyme disease
 Apr 2016 PPIs and risk of incident CKI, Apomorphine, Domperidone, SGLT2 inhibitors, Vitamin supplements and AMD, Alogliptin, Ascorbic acid, Vitamin D, Calcipotriol/betametasone ointment 
 Mar 2016 Spironolactone, Desmopressin, Ciclosporin eye drops, Abasaglar, Idelalisib, Nicotinamide, Ixazomib, Lidocaine 4% cream, Toujeo, Oxetacaine with Magnesium hydroxide and Aluminium Hydroxide, Mycophenylate, Folic acid
Feb 2016   Valproate, Nicorandil, Levonorgestrel-releasing intrauterine systems, Galantamine hydrobromide (Reminyl), Camcolit, Donepezil, Zoledex, Decapeptyl, Melatonin, Fosfomycin
Jan 2016 Opioids aware, Bisphosphonates, GlucoMen LX test strips, Glargine prescribing, compliance aid medications
Dec 2015 Co-proximal, SGLT2,Insuman Basal, Insuman Comb 25,Pioglitazone
Nov 2015 Hepatitis A and B immunisation (Twinrix/Ambrix), Omeprazole Orphenadrine, Fluoroquinolones, Nicorandil, Naloxone, PPIs
Sep/Oct 2015
Latanoprost (Xalatan brand), Denosumab, Mirabegron, simeprevir with sofosbuvir, amiodarone
July 2015 PPI, SGLT2s canagliflozin, dapagliflozin, empagliflozin, AKI, Lymes Disease, Branded Generics,
May / June 2015 Omeprazole. dicloverine, mebeverine, ibuprofen, Insulin Degludec, High Strength Insulins, Methotrexate, Bimatoprost, NICE IBS
April 2015 Hydroxyzine, codeine, Symbicort DuoResp Spiromax, Temazepam, Antiemetics
Extra Mar 2015 Pregabalin, Lyrica
Mar 2015 Oxycodone, Aqueous Cream, zopiclone, valproate, sodium valproate
Feb 2015 Just In Case, LMWH, COPD, Tiotropium, Vaccine, PPI & Clopidogrel, Rizatriptran, ONS, pregabalin
Jan 2015 Gabapentin, Pregabalin, Ivabradine, Isotretinoin, Diclofenac, Drug Driving,
Dec 2014 Nitrofurantoin, Ebesque XL, Quetiapine XL, Dispersable Fluoxetine,Cerazette, Yasmin,Varicella zoster immunoglobulin, DuoResp Spiromax, Symbicort, Relvar, Flutiform, Domperidone, Metoclopramide, Ondansetron, Rivaroxaban
Oct 2014 Gluco RX, Domperidone, Nalmefene, Selinco,
Sept 2014 Ropinerole, Pramipexole, Haloperidol, Sildenafil, anticoagulation, chronic kidney failiure
July 2014 Fentanyl patch, Ivabradine, Senna, Bisacodyl, Repevax, Boostrix-IPV 
June 2014 ACE inhibitor, ARB, Prednisolone, Quetiapine, vitamin D, Folic Acid
May 2014 Domperidone, Tramadol, Anti-histamines,Beclametasone, Budesonide, Fluticasone Furoate, Avamys 

Last updated by: Karen Hawkins on 27-06-2018 09:59